ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

Novartis India launches Pluvicto for prostate cancer treatment
Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision radiotherapy precisely targets cancer cells, offering a new treatment approach for metastatic prostate cancer. The t
Announcement as on 15 June 2026

India needs to remain attractive for innovation-led investment: Judith Love, Novartis
With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The company underscores the importance of collaboration to tackle obstacles like high costs and inadequate infrastructure.
Announcement as on 12 June 2026

Novartis expands India role in global drug development
Novartis is focusing on innovative medicines in India. The company is expanding its role in global drug development. Early-stage research is now happening in India. Novartis plans to launch more new medicines soon. This strategy reinforces its commitment t
Announcement as on 11 May 2026

Gainers & Losers: Novartis India and GMDC among 6 stocks in focus on Friday. Here’s why
Novartis India and GMDC led market action on Friday as broader indices recovered, while select stocks saw sharp gains and profit booking.
Announcement as on 20 February 2026

US FDA approves Novartis' gene therapy for rare muscle disorder
The US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular atrophy. Itvisma offers a new option for a broader patient group. The therapy aims to replace a faulty gene crucial for muscle functi
Announcement as on 25 November 2025

Announcements by Novartis first page | Next page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 1314.92
  • 12Day Average: 1359.63
  • 20Day Average: 1368.85
  • 50Day Average: 1179.51
  • 100Day Average: 1027.75
  • 150Day Average: 952.55
  • 200Day Average: 937.68

500672 Indicators & signals

Indicator MACD (12,26,9)

1336.72, 1300.15, 61.16
Indicator MACD is in positive zone

Indicator ADX (14)

6.83, 23.56, 20.55
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Tue Jun 2026 1321.40 1306.75 to 1329.90 2.03% 1.01 times
15 Mon Jun 2026 1295.10 1274.20 to 1315.00 -0.67% 0.47 times
12 Fri Jun 2026 1303.85 1293.50 to 1349.95 -1.91% 0.7 times
11 Thu Jun 2026 1329.30 1300.00 to 1344.00 0.33% 0.72 times
10 Wed Jun 2026 1324.95 1302.50 to 1338.00 -0.51% 1.01 times
09 Tue Jun 2026 1331.80 1311.30 to 1374.50 -1.67% 0.56 times
08 Mon Jun 2026 1354.40 1342.10 to 1431.15 -2.48% 0.51 times
05 Fri Jun 2026 1388.90 1351.45 to 1421.90 2.79% 0.57 times
04 Thu Jun 2026 1351.20 1273.15 to 1372.00 1.89% 1.61 times
03 Wed Jun 2026 1326.20 1308.00 to 1449.90 -9.47% 3.08 times
02 Tue Jun 2026 1464.85 1456.00 to 1527.00 -3.86% 0.75 times
01 Mon Jun 2026 1523.60 1498.80 to 1588.40 -2.05% 1.4 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top